Eascra Biotech, a nanomedicine startup, has named Dr. Anne Yau as Life Science Research Scientist, according to a May 4, 2026 press release. Dr. Yau, an expert in nanomedicine, will work at the Massachusetts Biomedical Initiatives (MBI) lab in Worcester to advance RNA therapeutics for musculoskeletal disease.
The company focuses on developing targeted nanocarriers for RNA-based treatments. Dr. Yau's role involves designing and testing these carriers to improve delivery and efficacy for conditions like osteoarthritis and muscle degeneration.
Dr. Yau previously held research positions at academic institutions and biotech firms, with a track record in nanomedicine and drug delivery. Her appointment is part of Eascra's expansion in the Worcester biotech hub.
